Supernus Pharmaceuticals, Inc. (SUPN)

NASDAQ: SUPN · Real-Time Price · USD

54.56

-0.53 (-0.96%)

At close: Mar 3, 2026, 4:00 PM EST

54.30

-0.26 (-0.48%)

Pre-market: Mar 4, 2026, 4:13 AM EST

Supernus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	128.45	69.33	75.05	93.12	203.43
Short-Term Investments	180.22	384.28	179.82	368.21	136.25
Cash & Short-Term Investments	308.67	453.61	254.87	461.33	339.68
Cash Growth	-31.95%	77.98%	-44.75%	35.81%	-19.61%
Accounts Receivable	187.8	142.08	144.16	165.5	148.93
Inventory	82.39	54.29	77.41	91.54	85.96
Other Current Assets	65.33	36.09	16.68	15.78	27.02
Total Current Assets	644.18	686.07	493.11	734.15	601.59
Net Property, Plant & Equipment	10.53	11.55	13.53	15.17	16.96
Other Intangible Assets	569.46	521.91	599.89	702.46	784.69
Goodwill	124.88	117.02	117.02	117.02	117.52
Long-Term Investments	-	-	16.62	93.9	119.17
Other Long-Term Assets	103.6	31.53	37.51	39.81	49.23
Total Assets	1,453	1,368	1,278	1,703	1,689
Accounts Payable	107.8	76.35	79.57	96.34	117.68
Accrued Expenses	161.1	168.71	154.27	151.67	132.72
Short-Term Debt	-	-	-	401.97	-
Other Current Liabilities	69.27	47.34	56.35	37.98	64.97
Total Current Liabilities	338.17	292.4	290.2	687.96	315.38
Long-Term Debt	-	-	-	-	379.25
Long-Term Leases	30.37	27.38	33.2	36	41.3
Other Long-Term Liabilities	22.4	12.56	32.77	92.35	137.37
Total Long-Term Liabilities	52.76	39.94	65.96	128.35	557.92
Total Liabilities	390.93	332.34	356.16	816.3	873.3
Common Stock	0.06	0.06	0.06	0.05	0
Additional Paid-in Capital	543.83	479.44	439.49	408.12	434.34
Accumulated Other Comprehensive Income	-0.04	-0.19	-0.59	-3.21	1.54
Retained Earnings	517.88	556.43	482.56	481.25	379.92
Shareholders' Equity	1,062	1,036	921.52	886.2	815.85
Total Liabilities & Equity	1,453	1,368	1,278	1,703	1,689
Total Debt	30.37	27.38	33.2	437.97	420.55
Net Cash (Debt)	278.31	426.23	221.68	23.37	-80.87
Net Cash Growth	-34.71%	92.27%	848.64%	-	-
Net Cash Per Share	4.93	7.62	3.99	0.38	-1.49
Book Value	1,062	1,036	921.52	886.2	815.85
Book Value Per Share	18.81	18.51	16.60	14.37	15.01
Tangible Book Value	367.38	396.8	204.61	66.72	-86.36
Tangible Book Value Per Share	6.51	7.09	3.69	1.08	-1.59

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q